Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer
Saved in:
| Published in: | Computational and Mathematical Methods in Medicine |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2023
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1864030188289916929 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Computational and Mathematical Methods in Medicine |
| description | |
| discipline_display | Natural Sciences |
| discipline_facet | Natural Sciences |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:16947 |
| institution | FRELIP |
| journal_source_facet | Computational and Mathematical Methods in Medicine |
| publishDate | 2023 |
| publishDateSort | 2023 |
| record_format | rss_article |
| spellingShingle | Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer Mathematics Natural Sciences — Mathematical Sciences Natural Sciences |
| sub_discipline_display | Natural Sciences — Mathematical Sciences |
| sub_discipline_facet | Natural Sciences — Mathematical Sciences |
| subject_display | Mathematics Natural Sciences — Mathematical Sciences Natural Sciences Mathematics Natural Sciences — Mathematical Sciences Natural Sciences |
| subject_facet | Mathematics Natural Sciences — Mathematical Sciences Natural Sciences |
| title | Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer |
| title_auth | Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer |
| title_full | Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer |
| title_fullStr | Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer |
| title_full_unstemmed | Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer |
| title_short | Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer |
| title_sort | retracted: efficacy and risk factors of pyrrotinib in second- and third-line treatments for her2-positive advanced breast cancer |
| topic | Mathematics Natural Sciences — Mathematical Sciences Natural Sciences |
| url | https://www.hindawi.com/journals/cmmm/2023/9868302/ |